Botulinum toxin as a therapeutic modality for headache

Detalhes bibliográficos
Autor(a) principal: Silva, Emilene Aparecida Ramos da
Data de Publicação: 2023
Outros Autores: Suguihara, Roberto Teruo, Muknicka, Daniella Pilon
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/43898
Resumo: Headache, popularly known as headache, is a common symptom in medical practice that can indicate serious problems. It can manifest itself episodic or continuously, with several associated symptoms, including nausea, vomiting, sensitivity to sensory stimuli, dizziness and irritability. Diagnosis of headache involves a detailed assessment of the patient's history and physical examination, aimed at categorizing the type of headache to determine appropriate treatment. Treatment varies depending on factors such as medical history and pain intensity, and may include a variety of medications. In cases of frequent and debilitating primary headaches, preventive treatment is indicated. Recently, botulinum toxin was approved by ANVISA as a preventive option for migraines when attacks are frequent and impair quality of life. In addition to medicinal options, non-drug approaches such as acupuncture, homeopathy, hypnotherapy and lifestyle adjustments are recommended as preventive measures. Botulinum toxin, derived from the bacteria Clostridium botulinum, is made up of different types, with type A being used to treat migraines. It works by weakening the muscles and providing pain relief, suggesting a direct impact on pain mechanisms. Therefore, the effectiveness of migraine treatment with botulinum toxin is a topic of interest in this study. Therefore, this narrative literature review study aims to analyze the scientific production on the treatment of migraine through the application of botulinum toxin.
id UNIFEI_e99a9c38cc73c2ad4671dd788db52bc3
oai_identifier_str oai:ojs.pkp.sfu.ca:article/43898
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Botulinum toxin as a therapeutic modality for headacheToxina botulínica como modalidad terapéutica para el dolor de cabezaToxina botulínica como modalidade terapêutica na cefaleiaBotulinum toxins, type AHeadache disordersFace.Toxinas botulínicas tipo ATrastornos de cefalalgiaCara.Toxinas botulínicas tipo ATranstornos da cefaleiaFace.Headache, popularly known as headache, is a common symptom in medical practice that can indicate serious problems. It can manifest itself episodic or continuously, with several associated symptoms, including nausea, vomiting, sensitivity to sensory stimuli, dizziness and irritability. Diagnosis of headache involves a detailed assessment of the patient's history and physical examination, aimed at categorizing the type of headache to determine appropriate treatment. Treatment varies depending on factors such as medical history and pain intensity, and may include a variety of medications. In cases of frequent and debilitating primary headaches, preventive treatment is indicated. Recently, botulinum toxin was approved by ANVISA as a preventive option for migraines when attacks are frequent and impair quality of life. In addition to medicinal options, non-drug approaches such as acupuncture, homeopathy, hypnotherapy and lifestyle adjustments are recommended as preventive measures. Botulinum toxin, derived from the bacteria Clostridium botulinum, is made up of different types, with type A being used to treat migraines. It works by weakening the muscles and providing pain relief, suggesting a direct impact on pain mechanisms. Therefore, the effectiveness of migraine treatment with botulinum toxin is a topic of interest in this study. Therefore, this narrative literature review study aims to analyze the scientific production on the treatment of migraine through the application of botulinum toxin.El dolor de cabeza, conocido popularmente como dolor de cabeza, es un síntoma común en la práctica médica que puede indicar problemas graves. Puede manifestarse episódica o continuamente, con varios síntomas asociados, entre ellos náuseas, vómitos, sensibilidad a estímulos sensoriales, mareos e irritabilidad. El diagnóstico de dolor de cabeza implica una evaluación detallada de la historia y el examen físico del paciente, con el objetivo de categorizar el tipo de dolor de cabeza para determinar el tratamiento adecuado. El tratamiento varía según factores como el historial médico y la intensidad del dolor, y puede incluir una variedad de medicamentos. En casos de dolores de cabeza primarios frecuentes y debilitantes, está indicado un tratamiento preventivo. Recientemente, la toxina botulínica fue aprobada por ANVISA como opción preventiva de las migrañas cuando las crisis son frecuentes y afectan la calidad de vida. Además de las opciones medicinales, se recomiendan como medidas preventivas enfoques no farmacológicos como la acupuntura, la homeopatía, la hipnoterapia y los ajustes en el estilo de vida. La toxina botulínica, derivada de la bacteria Clostridium botulinum, se compone de diferentes tipos, siendo el tipo A el que se utiliza para tratar las migrañas. Actúa debilitando los músculos y aliviando el dolor, lo que sugiere un impacto directo sobre los mecanismos del dolor. Por tanto, la eficacia del tratamiento de la migraña con toxina botulínica es un tema de interés en este estudio. Por lo tanto, este estudio de revisión narrativa de la literatura tiene como objetivo analizar la producción científica sobre el tratamiento de la migraña mediante la aplicación de toxina botulínica.A cefaleia, popularmente conhecida como dor de cabeça, é um sintoma comum na prática médica que pode indicar problemas graves. Ela pode se manifestar de maneira episódica ou contínua, com diversos sintomas associados, incluindo náuseas, vômitos, sensibilidade a estímulos sensoriais, tonturas e irritabilidade. O diagnóstico da cefaleia envolve uma avaliação detalhada da história do paciente e exame físico, visando a categorização do tipo de cefaleia para determinar o tratamento adequado. O tratamento varia de acordo com fatores como histórico médico e intensidade da dor, e pode incluir uma variedade de medicamentos. Em casos de cefaleias primárias frequentes e debilitantes, o tratamento preventivo é indicado. Recentemente, a toxina botulínica foi aprovada pela ANVISA como opção preventiva para enxaqueca quando as crises são frequentes e prejudicam a qualidade de vida. Além das opções medicamentosas, abordagens não medicamentosas, como acupuntura, homeopatia, hipnoterapia e ajustes no estilo de vida, são recomendadas como medidas preventivas. A toxina botulínica, derivada da bactéria Clostridium botulinum, é composta por diferentes tipos, sendo o tipo A usado para tratar enxaqueca. Ela atua enfraquecendo a musculatura e proporcionando alívio da dor, sugerindo um impacto direto nos mecanismos da dor. Portanto, a eficácia do tratamento de enxaqueca com toxina botulínica é um tópico de interesse neste estudo. Diante disso, este estudo de revisão narrativa da literatura tem como objetivo analisar a produção científica sobre o tratamento da enxaqueca por meio da aplicação da toxina botulínica.Research, Society and Development2023-11-13info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/4389810.33448/rsd-v12i12.43898Research, Society and Development; Vol. 12 No. 12; e52121243898Research, Society and Development; Vol. 12 Núm. 12; e52121243898Research, Society and Development; v. 12 n. 12; e521212438982525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/43898/35282Copyright (c) 2023 Emilene Aparecida Ramos da Silva; Roberto Teruo Suguihara; Daniella Pilon Muknickahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSilva, Emilene Aparecida Ramos da Suguihara, Roberto Teruo Muknicka, Daniella Pilon 2023-11-24T09:58:06Zoai:ojs.pkp.sfu.ca:article/43898Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2023-11-24T09:58:06Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Botulinum toxin as a therapeutic modality for headache
Toxina botulínica como modalidad terapéutica para el dolor de cabeza
Toxina botulínica como modalidade terapêutica na cefaleia
title Botulinum toxin as a therapeutic modality for headache
spellingShingle Botulinum toxin as a therapeutic modality for headache
Silva, Emilene Aparecida Ramos da
Botulinum toxins, type A
Headache disorders
Face.
Toxinas botulínicas tipo A
Trastornos de cefalalgia
Cara.
Toxinas botulínicas tipo A
Transtornos da cefaleia
Face.
title_short Botulinum toxin as a therapeutic modality for headache
title_full Botulinum toxin as a therapeutic modality for headache
title_fullStr Botulinum toxin as a therapeutic modality for headache
title_full_unstemmed Botulinum toxin as a therapeutic modality for headache
title_sort Botulinum toxin as a therapeutic modality for headache
author Silva, Emilene Aparecida Ramos da
author_facet Silva, Emilene Aparecida Ramos da
Suguihara, Roberto Teruo
Muknicka, Daniella Pilon
author_role author
author2 Suguihara, Roberto Teruo
Muknicka, Daniella Pilon
author2_role author
author
dc.contributor.author.fl_str_mv Silva, Emilene Aparecida Ramos da
Suguihara, Roberto Teruo
Muknicka, Daniella Pilon
dc.subject.por.fl_str_mv Botulinum toxins, type A
Headache disorders
Face.
Toxinas botulínicas tipo A
Trastornos de cefalalgia
Cara.
Toxinas botulínicas tipo A
Transtornos da cefaleia
Face.
topic Botulinum toxins, type A
Headache disorders
Face.
Toxinas botulínicas tipo A
Trastornos de cefalalgia
Cara.
Toxinas botulínicas tipo A
Transtornos da cefaleia
Face.
description Headache, popularly known as headache, is a common symptom in medical practice that can indicate serious problems. It can manifest itself episodic or continuously, with several associated symptoms, including nausea, vomiting, sensitivity to sensory stimuli, dizziness and irritability. Diagnosis of headache involves a detailed assessment of the patient's history and physical examination, aimed at categorizing the type of headache to determine appropriate treatment. Treatment varies depending on factors such as medical history and pain intensity, and may include a variety of medications. In cases of frequent and debilitating primary headaches, preventive treatment is indicated. Recently, botulinum toxin was approved by ANVISA as a preventive option for migraines when attacks are frequent and impair quality of life. In addition to medicinal options, non-drug approaches such as acupuncture, homeopathy, hypnotherapy and lifestyle adjustments are recommended as preventive measures. Botulinum toxin, derived from the bacteria Clostridium botulinum, is made up of different types, with type A being used to treat migraines. It works by weakening the muscles and providing pain relief, suggesting a direct impact on pain mechanisms. Therefore, the effectiveness of migraine treatment with botulinum toxin is a topic of interest in this study. Therefore, this narrative literature review study aims to analyze the scientific production on the treatment of migraine through the application of botulinum toxin.
publishDate 2023
dc.date.none.fl_str_mv 2023-11-13
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/43898
10.33448/rsd-v12i12.43898
url https://rsdjournal.org/index.php/rsd/article/view/43898
identifier_str_mv 10.33448/rsd-v12i12.43898
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/43898/35282
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 12 No. 12; e52121243898
Research, Society and Development; Vol. 12 Núm. 12; e52121243898
Research, Society and Development; v. 12 n. 12; e52121243898
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052633645580288

Registros relacionados